Q2 2022 Holdings
Filed 2022-08-11 | 37 holdings | $125.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $98.1M | 7,648,268 | 78.1% |
| Cytokinetics Inc.(CYTK) | Common | 23282W605 | $7.6M | 194,246 | 6.1% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $6.8M | 366,676 | 5.4% |
| Biocryst Pharmaceuticals Inc.(BCRX) | Common | 09058V103 | $6.8M | 639,089 | 5.4% |
| Arcutis Biotherapeutics inc(ARQT) | Common | 03969K108 | $5.5M | 258,500 | 4.4% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $590.0K | 239,888 | 0.5% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $36.0K | 1,745,943 | 0.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $22.9K | 1,639,849 | 0.0% |
| Merus N.V. | Common | N5749R100 | $20.8K | 919,482 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $15.5K | 299,409 | 0.0% |
| Iovance Biotherapeutics Inc Com(IOVA) | Common | 462260100 | $13.2K | 1,200,000 | 0.0% |
| Geron Corporation(GERN) | Common | 374163103 | $13.1K | 8,434,991 | 0.0% |
| Inhibrx, Inc.(INBXUSD) | Common | 45720L107 | $11.6K | 1,023,325 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $9.8K | 3,370,982 | 0.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $9.8K | 2,388,011 | 0.0% |
| Travere Therapeutics Inc.(TVTX) | Common | 89422G107 | $6.7K | 277,950 | 0.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $6.7K | 443,702 | 0.0% |
| Harmony Biosciences Hldgs Inc.(HRMY) | Common | 413197104 | $6.7K | 137,517 | 0.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $6.1K | 3,196,707 | 0.0% |
| Mirum Pharmaceuticals Inc.(MIRM) | Common | 604749101 | $5.6K | 288,531 | 0.0% |
| Reata Pharmaceuticals inc(RETAEUR) | Common | 75615P103 | $5.5K | 180,000 | 0.0% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $5.3K | 495,603 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $5.0K | 3,425,202 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $4.2K | 856,798 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $3.8K | 3,244,650 | 0.0% |
| Madrigal Pharmaceuticals inc(MDGL) | Common | 558868105 | $3.2K | 45,000 | 0.0% |
| Inozyme Pharma Inc. | Common | 45790W108 | $3.2K | 664,980 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $3.0K | 2,377,031 | 0.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $2.8K | 146,041 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $2.7K | 334,384 | 0.0% |
| Karuna Therapeutics inc | Common | 48576A100 | $2.5K | 20,000 | 0.0% |
| Provention Bio Inc(PRVBUSD) | Common | 74374N102 | $2.4K | 592,435 | 0.0% |
| Essa Pharma, Inc.(EPIEUR) | Common | 29668H708 | $2.1K | 660,892 | 0.0% |
| Phathom Pharmaceuticals inc(PHAT) | Common | 71722W107 | $1.6K | 193,326 | 0.0% |
| Neogenomics Inc.(NEO) | Common | 64049M209 | $1.1K | 135,573 | 0.0% |
| Avadel Pharmaceuticals Plc | ADR | 05337M104 | $1.0K | 412,363 | 0.0% |
| Avrobio, Inc. | Common | 05455M100 | $596 | 647,918 | 0.0% |